GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 166 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,026,000 | +12.0% | 42,926 | -31.6% | 0.01% | -14.3% |
| Q4 2020 | $916,000 | +65.6% | 62,745 | +61.3% | 0.01% | 0.0% |
| Q3 2020 | $553,000 | -66.2% | 38,910 | -65.1% | 0.01% | -73.1% |
| Q2 2020 | $1,638,000 | +169.9% | 111,335 | -24.4% | 0.03% | +62.5% |
| Q1 2020 | $607,000 | -46.6% | 147,258 | -37.7% | 0.02% | +128.6% |
| Q4 2019 | $1,137,000 | -33.7% | 236,413 | -16.4% | 0.01% | -53.3% |
| Q3 2019 | $1,715,000 | +45.1% | 282,946 | +55.3% | 0.02% | +25.0% |
| Q2 2019 | $1,182,000 | +246.6% | 182,178 | +278.8% | 0.01% | +200.0% |
| Q1 2019 | $341,000 | +348.7% | 48,094 | +244.9% | 0.00% | +300.0% |
| Q1 2018 | $76,000 | +46.2% | 13,943 | +11.7% | 0.00% | 0.0% |
| Q4 2017 | $52,000 | -69.6% | 12,480 | -10.8% | 0.00% | -85.7% |
| Q4 2016 | $171,000 | +216.7% | 13,986 | +37.1% | 0.01% | +75.0% |
| Q1 2016 | $54,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
| Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
| First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
| WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
| Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
| EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
| OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
| TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
| Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
| G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |